Human Factor XIII (Factor 13) Deficient Serum

<strong>Human Factor XIII (Factor 13) Deficient Serum</strong>_x000D_ <strong>Catalog number:</strong> B2015410_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> N/A_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Coagulation Factor XIII, Coagulation Factor 13, F13, FXIII, F13A, F13a1, Transglutaminase A chain, Fibrin Stabilizing Factor, Fibrinoligase FSF (A subunit), Protein Glutamine gamma Glutamyltransferase A chain, TGase, Transglutaminase A Chain_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Aihara M, Sawada Y, Takami H, Kariya K, Kudo I, Kimura A, Yoshida Y. Factor XIII is not involved in human platelet-collagen interaction Tohoku J Exp Med. 1989 Sep;159(1):37-44._x000D_ 2: Ichinose A, Souri M. Reduced difference of α₂-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies Int J Hematol. 2012 Jan;95(1):47-50._x000D_ 3: Apti Sengun O, Ergun T, Guctekin T, Alibaz Oner F. Endothelial dysfunction, thrombophilia, and nailfold capillaroscopic features in livedoid vasculopathy Microvasc Res. 2023 Nov;150:104591._x000D_ 4: Krøll J. The subunit composition of factor XIII proteins in normal and factor XIII deficient plasma and serum analysed by line immunoelectrophoresis Clin Chim Acta. 1989 Feb 22;179(3):279-84._x000D_ 5: Yazdian M, Groeben H, Ataseven B, Schneider S, Baert T, Bommert M, Traut A, Elfers-Wassenhoven A, Brüß U, Schwameis R, du Bois A, Wagner U, Harter P. The role of factor XIII in surgery for advanced stage of epithelial ovarian cancer Arch Gynecol Obstet. 2022 May;305(5):1311-1318._x000D_ 6: Girolami A, Cosi E, Santarossa C, Ferrari S, Luigia Randi M. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII Semin Thromb Hemost. 2015 Jun;41(4):366-73._x000D_ 7: He T, Ling J, Yang J. Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis Sci Rep. 2023 Jun 3;13(1):9050._x000D_ 8: Kawai R, Suzuki S, Tanaka A, Yamazaki M, Inoue T, Katagiri K. Association of lethal acquired factor XIII deficiency and type 1 diabetes mellitus with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with high levels of serum thymus and activation-regulated chemokine J Dermatol. 2021 Jul;48(7):e341-e342._x000D_ 9: Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, Hosoya M. Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment Fukushima J Med Sci. 2013;59(1):15-26._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/14872429">10: Pihusch M. Bleeding complications after hematopoietic stem cell transplantation Semin Hematol. 2004 Jan;41(1 Suppl 1):93-100. </a>_x000D_ _x000D_ <strong>Products Related to Human Factor XIII (Factor 13) Deficient Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Biofluids/"> Biofluids</a>